Malignant gliomas are notoriously difficult cancers to treat. The majority of current therapeutics target the traditional oncological traits of glioma cells. In this Review, Cuddapahet al. explore the unique biology of glioma cells and propose novel, brain-specific therapeutic targets.
- Vishnu Anand Cuddapah
- Stefanie Robel
- Harald Sontheimer